IGF-1 LR3 vs CJC-1295 + Ipamorelin

IGF-1 LR3 wins for: Maximum anabolic potential, rapid muscle protein synthesis, and targeted post-workout application. LR3 is the compound for users already running high-level protocols, looking to force-feed hypertrophy through direct IGF-1 receptor activation. Results show up quickly—big pumps, better recovery—but at the cost of a harder side effect profile (notably hypoglycemia) and a short cycle window before downregulation kills returns.

CJC-1295 + Ipamorelin wins for: Safety profile, sustainable long-term protocols, and improvements in sleep, recovery, skin, and fat loss. The combo drives your GH/IGF axis up through natural hormone release, not receptor overstimulation; this means slower, steadier changes, but you avoid most of the sharp risks (especially hypoglycemia) and can run cycles much longer without shutdown or diminishing returns.

Pick IGF-1 LR3 if:

• You're already running AAS, GH, and insulin and want the next lever for direct anabolic drive
• You want rapid, post-workout muscle protein synthesis and enhanced nutrient partitioning
• You can manage injection timing, carb intake, and short cycle windows (3–6 weeks)
• Localized muscle growth (site enhancement) is a goal
• You're prepared to monitor for hypoglycemia and have your nutrition dialed in

Pick CJC-1295 + Ipamorelin if:

• You're looking for a sustainable, long-term protocol for better sleep, recovery, and skin/connective tissue health
• You want slow-but-steady body re-comp and subtle fat loss without a big side effect burden
• You're new to peptides or want minimal risk/monitoring
• You value a protocol you can overlap with other looksmaxxing stacks (hair, tan, ED, etc.) with low interaction risk
• Blood sugar control, prolactin, or cortisol management is a concern